An investigation study of the glycemic index (GI): an open-label trial - An investigation study of the glycemic index (GI)

ORTHOMEDICO Inc.0 sites10 target enrollmentFebruary 21, 2020

ConditionsHealthy Japanese subjects

Overview

Phase: 未知
Intervention: Not specified
Conditions: Healthy Japanese subjects
Sponsor: ORTHOMEDICO Inc.
Enrollment: 10
Status: Completed
Last Updated: 2 years ago

Overview Investigators Eligibility Criteria Outcomes Similar Trials

Overview

Brief Summary

No summary available.

Registry

who.int

Start Date

February 21, 2020

End Date

May 16, 2020

Last Updated

2 years ago

Study Type

Interventional

Sex

All

Investigators

Sponsor

ORTHOMEDICO Inc.

Eligibility Criteria

Inclusion Criteria

Not provided

Exclusion Criteria

•1\. Subjects who are undergoing medical treatment or have a medical history of malignant tumor, heart failure, or myocardial infarction 2\. Subjects who have a pacemaker or an implantable cardioverter defibrillator (ICD) 3\. Currently undergoing treatment for any of the following chronic disease: cardiac arrhythmia, liver disorder, kidney disorder, cerebrovascular disorder, rheumatism, diabetes mellitus, dyslipidemia, hypertension, or any other chronic diseases 4\. Subjects who have food allergies and/or food intolerances. Particularly, subjects who have lactose intolerance. 5\. Subjects who have abnormal glucose tolerance 6\. Subjects who take medications known to affect glucose tolerance 7\. Subjects who have used insulin to treat diabetes or taken antihyperglycemic drugs 8\. Subjects who are the presence or under the treatment of disease which influence digestion and absorption of nutrients 9\. Subjects who are taking steroids, protease inhibitors, or antipsychotics 10\. Subjects who use or take "Foods for Specified Health Uses", "Foods with Functional Claims", or other functional food/beverage in daily 11\. Subjects who are currently taking medicines (include herbal medicines) and supplements 12\. Subjects who are allergic to medicines and/or the test food related products 13\. Subjects who are pregnant, breast\-feeding, and planning to become pregnant 14\. Subjects who have been enrolled in other clinical trials within the last three months before the agreement to participate in this trial or plan to participate another trial during this trial 15\. Subjects who are judged as ineligible to participate in the study by the physician